S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
NASDAQ:PETQ

PetIQ Stock Forecast, Price & News

$21.17
-0.93 (-4.21%)
(As of 11/26/2021 04:00 PM ET)
Add
Compare
Today's Range
$20.60
$22.08
50-Day Range
$21.17
$26.23
52-Week Range
$20.60
$46.00
Volume
339,752 shs
Average Volume
401,058 shs
Market Capitalization
$622.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.42
30 days | 90 days | 365 days | Advanced Chart
Receive PETQ News and Ratings via Email

Sign-up to receive the latest news and ratings for PetIQ and its competitors with MarketBeat's FREE daily newsletter.


PetIQ logo

About PetIQ

PetIQ, Inc. is a holding company, which engages in the manufacture, procurement, packaging, and distribution of pet health and wellness products. It operates through the Products and Services segments. The Products segment produces and distributes pet medication and health and wellness products to the retail channel. The Services segment represents all veterinary services, and related product sales provided by the firm directly to consumers. Its brands include Advecta, Betsy Farms, Delightibles, Tex Ranch, Mimis Market, and PetLock. The company was founded by McCord Christensen in 2010 and is headquartered in Eagle, ID.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Drugs, proprietaries, & sundries
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PETQ
Fax
N/A
Employees
2,072
Year Founded
N/A

Sales & Book Value

Annual Sales
$780.05 million
Cash Flow
$1.28 per share
Book Value
$8.95 per share

Profitability

Net Income
$-77.47 million
Pretax Margin
-1.72%

Debt

Price-To-Earnings

Miscellaneous

Free Float
26,781,000
Market Cap
$622.57 million
Optionable
Optionable

Company Calendar

Last Earnings
5/05/2021
Today
11/28/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
2/24/2022

MarketRank

Overall MarketRank

2.29 out of 5 stars

Medical Sector

287th out of 1,391 stocks

Drugs, Proprietaries, & Sundries Industry

6th out of 7 stocks

Analyst Opinion: 3.5Community Rank: 4.4Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -












PetIQ (NASDAQ:PETQ) Frequently Asked Questions

Is PetIQ a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PetIQ in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" PetIQ stock.
View analyst ratings for PetIQ
or view top-rated stocks.

How has PetIQ's stock price been impacted by COVID-19 (Coronavirus)?

PetIQ's stock was trading at $22.59 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, PETQ stock has decreased by 6.3% and is now trading at $21.17.
View which stocks have been most impacted by COVID-19
.

When is PetIQ's next earnings date?

PetIQ is scheduled to release its next quarterly earnings announcement on Thursday, February 24th 2022.
View our earnings forecast for PetIQ
.

How were PetIQ's earnings last quarter?

PetIQ, Inc. (NASDAQ:PETQ) released its earnings results on Wednesday, May, 5th. The company reported $0.39 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.04 by $0.35. The company earned $254.35 million during the quarter, compared to analyst estimates of $211.07 million. PetIQ had a positive trailing twelve-month return on equity of 7.36% and a negative net margin of 1.36%.
View PetIQ's earnings history
.

What guidance has PetIQ issued on next quarter's earnings?

PetIQ updated its FY 2021 earnings guidance on Wednesday, September, 1st. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $950 million-$950 million, compared to the consensus revenue estimate of $958.97 million.

What price target have analysts set for PETQ?

2 Wall Street analysts have issued twelve-month target prices for PetIQ's shares. Their forecasts range from $32.00 to $36.00. On average, they anticipate PetIQ's share price to reach $34.00 in the next twelve months. This suggests a possible upside of 60.6% from the stock's current price.
View analysts' price targets for PetIQ
or view top-rated stocks among Wall Street analysts.

Who are PetIQ's key executives?

PetIQ's management team includes the following people:

What is Cord Christensen's approval rating as PetIQ's CEO?

10 employees have rated PetIQ CEO Cord Christensen on Glassdoor.com. Cord Christensen has an approval rating of 89% among PetIQ's employees.

What other stocks do shareholders of PetIQ own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PetIQ investors own include Micron Technology (MU), NVIDIA (NVDA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Exelixis (EXEL), Intel (INTC), CVS Health (CVS), QUALCOMM (QCOM), Editas Medicine (EDIT) and Gilead Sciences (GILD).

When did PetIQ IPO?

(PETQ) raised $86 million in an initial public offering (IPO) on Friday, July 21st 2017. The company issued 5,700,000 shares at $14.00-$16.00 per share. Jefferies and William Blair acted as the underwriters for the IPO and Oppenheimer, Raymond James and SunTrust Robinson Humphrey were co-managers.

What is PetIQ's stock symbol?

PetIQ trades on the NASDAQ under the ticker symbol "PETQ."

Who are PetIQ's major shareholders?

PetIQ's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Macquarie Group Ltd. (10.28%), BlackRock Inc. (7.99%), Geneva Capital Management LLC (4.41%), Boston Partners (4.14%), FIL Ltd (3.93%) and Minneapolis Portfolio Management Group LLC (3.65%). Company insiders that own PetIQ stock include John Newland, Mark L First, Mccord Christensen, Michael A Smith, Michael A Smith, Robert Michael Herrman, Ronald Kennedy, Susan Sholtis and Will Santana.
View institutional ownership trends for PetIQ
.

Which major investors are selling PetIQ stock?

PETQ stock was sold by a variety of institutional investors in the last quarter, including Royal Bank of Canada, Russell Investments Group Ltd., Morgan Stanley, Ensign Peak Advisors Inc, Dimensional Fund Advisors LP, Raymond James & Associates, Wasatch Advisors Inc., and Thornburg Investment Management Inc.. Company insiders that have sold PetIQ company stock in the last year include John Newland, Mark L First, Mccord Christensen, Michael A Smith, Robert Michael Herrman, Ronald Kennedy, and Susan Sholtis.
View insider buying and selling activity for PetIQ
or view top insider-selling stocks.

Which major investors are buying PetIQ stock?

PETQ stock was purchased by a variety of institutional investors in the last quarter, including Boston Partners, Minneapolis Portfolio Management Group LLC, Brandywine Global Investment Management LLC, Millennium Management LLC, Macquarie Group Ltd., FIL Ltd, Eagle Asset Management Inc., and Goldman Sachs Group Inc.. Company insiders that have bought PetIQ stock in the last two years include Michael A Smith, and Robert Michael Herrman.
View insider buying and selling activity for PetIQ
or or view top insider-buying stocks.

How do I buy shares of PetIQ?

Shares of PETQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is PetIQ's stock price today?

One share of PETQ stock can currently be purchased for approximately $21.17.

How much money does PetIQ make?

PetIQ has a market capitalization of $622.57 million and generates $780.05 million in revenue each year. The company earns $-77.47 million in net income (profit) each year or ($0.46) on an earnings per share basis.

How many employees does PetIQ have?

PetIQ employs 2,072 workers across the globe.

What is PetIQ's official website?

The official website for PetIQ is www.petiq.com.

Where are PetIQ's headquarters?

PetIQ is headquartered at 923 S. Bridgeway Pl., EAGLE ID, 83616.

How can I contact PetIQ?

PetIQ's mailing address is 923 S. Bridgeway Pl., EAGLE ID, 83616. The company can be reached via phone at (208) 939-8900 or via email at [email protected].


This page was last updated on 11/28/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.